Fecal microbiota transplantation compared with prednisolone in severe alcoholic hepatitis patients: a randomized trial.

Apurva PandeShvetank SharmaVikas KhillanArchana RastogiVinod AroraSaggere Muralikrishna ShasthryRajan VijayaraghavanRakesh JagdishManoj KumarGuresh KumarStanislas MondotJoél DoreShiv Kumar Sarin

Published in: Hepatology international (2022)

In severe alcoholic hepatitis, FMT is safe and improves 90-day survival and reduces infections by favorably modulating microbial communities. It can be a useful alternative to prednisolone therapy.

Keyphrases

end stage renal disease
liver injury
ejection fraction
drug induced
early onset
chronic kidney disease
prognostic factors
mesenchymal stem cells
patient reported
smoking cessation